Observational studyEuropean journal of hospital pharmacy : science and practice2023
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.
Sandra Rotea-Salvo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.